Alphavax

RNA particle vaccine technology company developing anti-infective and anti-cancer vaccines

placeDurham, North Carolina, United States calendar_todayFounded 1997 groups9 employees language alphavax.com

Innovation

17 patent families (16 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 3,698 times.

YearFilings
20129
20139
20148
20157
20163
20174
20185
20192
20207
20212
20221

Investor mix

3 investors on record.

Investor typeCountShare
Accelerator & incubator133%
Other / undisclosed267%
Coming soon